JP2024503277A5 - - Google Patents

Info

Publication number
JP2024503277A5
JP2024503277A5 JP2023539809A JP2023539809A JP2024503277A5 JP 2024503277 A5 JP2024503277 A5 JP 2024503277A5 JP 2023539809 A JP2023539809 A JP 2023539809A JP 2023539809 A JP2023539809 A JP 2023539809A JP 2024503277 A5 JP2024503277 A5 JP 2024503277A5
Authority
JP
Japan
Application number
JP2023539809A
Other languages
Japanese (ja)
Other versions
JP2024503277A (ja
JPWO2022147442A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/073142 external-priority patent/WO2022147442A1/en
Publication of JP2024503277A publication Critical patent/JP2024503277A/ja
Publication of JP2024503277A5 publication Critical patent/JP2024503277A5/ja
Publication of JPWO2022147442A5 publication Critical patent/JPWO2022147442A5/ja
Pending legal-status Critical Current

Links

JP2023539809A 2020-12-29 2021-12-28 活性化抗原担体の製剤 Pending JP2024503277A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063131457P 2020-12-29 2020-12-29
US63/131,457 2020-12-29
PCT/US2021/073142 WO2022147442A1 (en) 2020-12-29 2021-12-28 Formulations of activating antigen carriers

Publications (3)

Publication Number Publication Date
JP2024503277A JP2024503277A (ja) 2024-01-25
JP2024503277A5 true JP2024503277A5 (https=) 2024-12-25
JPWO2022147442A5 JPWO2022147442A5 (https=) 2024-12-25

Family

ID=80123528

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023539809A Pending JP2024503277A (ja) 2020-12-29 2021-12-28 活性化抗原担体の製剤

Country Status (6)

Country Link
US (1) US20220233676A1 (https=)
EP (1) EP4271407A1 (https=)
JP (1) JP2024503277A (https=)
CN (1) CN116847880A (https=)
CA (1) CA3203709A1 (https=)
WO (1) WO2022147442A1 (https=)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770478B2 (en) * 2000-02-10 2004-08-03 The Regents Of The University Of California Erythrocytic cells and method for preserving cells
WO2005072523A2 (en) * 2004-02-02 2005-08-11 I.M.T. Interface Multigrad Technology Ltd. Biological material and methods and solutions for preservation thereof
ES2482192T3 (es) * 2007-05-31 2014-08-01 Academisch Ziekenhuis Leiden H.O.D.N. Lumc Vacunación intradérmica del péptido de HPV
CN107058101B (zh) 2011-10-17 2021-06-01 麻省理工学院 细胞内传递
EP3033184B1 (en) 2013-08-16 2021-03-31 Massachusetts Institute of Technology Selective delivery of material to cells
ES2865825T3 (es) * 2014-04-01 2021-10-18 Rubius Therapeutics Inc Procedimientos y composiciones para inmunomodulación
JP7523203B2 (ja) * 2014-10-31 2024-07-26 マサチューセッツ インスティテュート オブ テクノロジー 生体分子の免疫細胞への送達
SG10201912910PA (en) 2015-07-09 2020-02-27 Massachusetts Inst Technology Delivery of materials to anucleate cells
ES2930017T3 (es) 2015-09-04 2022-12-05 Sqz Biotechnologies Co Suministro intracelular de biomoléculas mediado por una superficie con poros
CN108779475A (zh) * 2016-01-12 2018-11-09 Sqz生物技术公司 复合物的细胞内递送
JP7602702B2 (ja) 2016-05-03 2024-12-19 ステムセル テクノロジーズ カナダ インコーポレーテッド 寛容性を誘導するための生体分子の細胞内送達
KR102490952B1 (ko) 2016-05-03 2023-01-19 에스큐지 바이오테크놀로지스 컴퍼니 관용을 유도하는 생체분자의 세포내 전달
EP3765068A2 (en) 2018-03-12 2021-01-20 SQZ Biotechnologies Company Intracellular delivery of biomolecules to modify immune response
US12599656B2 (en) 2018-03-12 2026-04-14 Stemcell Technologies Canada Inc. Methods for treating HPV-associated diseases
KR20210070338A (ko) 2018-10-04 2021-06-14 에스큐지 바이오테크놀로지스 컴퍼니 항원 제시 세포 기능을 증진시키기 위한 생체분자의 세포내 전달
WO2020154696A1 (en) 2019-01-25 2020-07-30 Sqz Biotechnologies Company Anucleate cell-derived vaccines
CA3131701A1 (en) 2019-02-28 2020-09-03 Sqz Biotechnologies Company Delivery of biomolecules to pbmcs to modify an immune response
EP4188425B1 (en) * 2020-07-29 2025-05-14 Stemcell Technologies Canada Inc. Methods to stimulate immune responses to mutant ras using anucleate cells

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
JP2022522351A5 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
JP2023539370A5 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
JP2024503277A5 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)